Xylem Statistics
Share Statistics
Xylem has 243.35M
shares outstanding. The number of shares has increased by 0.25%
in one year.
| Shares Outstanding | 243.35M |
| Shares Change (YoY) | 0.25% |
| Shares Change (QoQ) | 0.04% |
| Owned by Institutions (%) | 90.7% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 58 |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 3.1M, so 1.28% of the outstanding
shares have been sold short.
| Short Interest | 3.1M |
| Short % of Shares Out | 1.28% |
| Short % of Float | 1.63% |
| Short Ratio (days to cover) | 1.38 |
Valuation Ratios
The PE ratio is 31.62 and the forward
PE ratio is 23.43.
Xylem's PEG ratio is
1.03.
| PE Ratio | 31.62 |
| Forward PE | 23.43 |
| PS Ratio | 3.29 |
| Forward PS | 3 |
| PB Ratio | 2.64 |
| P/FCF Ratio | 29.87 |
| PEG Ratio | 1.03 |
Financial Ratio HistoryEnterprise Valuation
Xylem has an Enterprise Value (EV) of 29.04B.
| EV / Sales | 3.39 |
| EV / EBITDA | 17.78 |
| EV / EBIT | 22.99 |
| EV / FCF | 30.82 |
Financial Position
The company has a current ratio of 1.76,
with a Debt / Equity ratio of 0.19.
| Current Ratio | 1.76 |
| Quick Ratio | 1.33 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 1.23 |
| Debt / FCF | 2.14 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 8.36% and Return on Invested Capital is 6.19%.
| Return on Equity | 8.36% |
| Return on Assets | 5.39% |
| Return on Invested Capital | 6.19% |
| Revenue Per Employee | $372,260.87 |
| Profits Per Employee | $38,695.65 |
| Employee Count | 23,000 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 5.37 |
Taxes
| Income Tax | 197M |
| Effective Tax Rate | 18.12% |
Stock Price Statistics
The stock price has increased by -14.14% in the
last 52 weeks. The beta is 1.1, so Xylem's
price volatility has been higher than the market average.
| Beta | 1.1 |
| 52-Week Price Change | -14.14% |
| 50-Day Moving Average | 118.59 |
| 200-Day Moving Average | 125.54 |
| Relative Strength Index (RSI) | 61.02 |
| Average Volume (20 Days) | 1,841,103 |
Income Statement
In the last 12 months, Xylem had revenue of 8.56B
and earned 890M
in profits. Earnings per share was 3.67.
| Revenue | 8.56B |
| Gross Profit | 3.21B |
| Operating Income | 1.07B |
| Net Income | 890M |
| EBITDA | 1.63B |
| EBIT | 1.07B |
| Earnings Per Share (EPS) | 3.67 |
Full Income StatementBalance Sheet
The company has 1.12B in cash and 2.02B in
debt, giving a net cash position of -895M.
| Cash & Cash Equivalents | 1.12B |
| Total Debt | 2.02B |
| Net Cash | -895M |
| Retained Earnings | 3.14B |
| Total Assets | 16.56B |
| Working Capital | 1.92B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 1.26B
and capital expenditures -321M, giving a free cash flow of 942M.
| Operating Cash Flow | 1.26B |
| Capital Expenditures | -321M |
| Free Cash Flow | 942M |
| FCF Per Share | 3.88 |
Full Cash Flow StatementMargins
Gross margin is 37.51%, with operating and profit margins of 12.53% and 10.39%.
| Gross Margin | 37.51% |
| Operating Margin | 12.53% |
| Pretax Margin | 12.7% |
| Profit Margin | 10.39% |
| EBITDA Margin | 19.07% |
| EBIT Margin | 12.53% |
| FCF Margin | 11% |
